Valuation: Zoetis Inc.

Market Cap 31.98B 27.99B 25.79B 23.91B 45.38B 3,035B 46.12B 309B 120B 1,498B 120B 117B 5,178B P/E 2026 *
11.9x
P/E 2027 * 10.9x
Enterprise Value 38.71B 33.87B 31.22B 28.94B 54.93B 3,674B 55.81B 374B 146B 1,813B 145B 142B 6,267B EV / Sales 2026 *
3.97x
EV / Sales 2027 * 3.72x
Free-Float
83.58%
Yield 2026 *
2.83%
Yield 2027 * 3.03%
1 day+1.15%
1 week+6.16%
Current month+6.16%
1 month-3.97%
3 months-34.68%
6 months-39.29%
Current year-39.37%
1 week 72.9
Extreme 72.9
77.99
1 month 71.47
Extreme 71.47
82.98
Current year 71.47
Extreme 71.47
132.49
1 year 71.47
Extreme 71.47
161.77
3 years 71.47
Extreme 71.47
201.92
5 years 71.47
Extreme 71.47
249.27
10 years 46.86
Extreme 46.86
249.27
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 54 2021-05-31
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Date Insider Type Main position Quantity % Market Cap.
Jun. 17Free

Director

318 0.0001%
Jun. 14Other

Executive Vice President

27,676 0.0066%
Jun. 09Don

Chairman

-1,209 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.15%+6.16%-51.42%-54.36% 31.98B
-1.95%+0.12%+70.28%+145.42% 12.31B
-4.51%+1.26%-16.75%+0.25% 3.65B
+0.46%-1.80%-1.66%+30.60% 3.13B
-0.86%+6.58%+56.51%+32.81% 2.03B
-0.17%+3.25%-27.80%+18.24% 1.65B
-2.96%+5.48%+10.77%+130.80% 1.34B
-1.63%+5.85%-20.23%-9.49% 1.05B
-3.32%+0.82%-16.39%-47.96% 920M
+1.26%+2.26%-3.07%-17.33% 963M
Average -1.25%+2.36%+0.02%+22.90% 5.9B
Weighted average by Cap. -0.20%+3.58%-13.59%+5.92%

Financials

2026 *2027 *
Net sales 9.76B 8.54B 7.87B 7.3B 13.85B 926B 14.07B 94.39B 36.71B 457B 36.65B 35.85B 1,580B 10.16B 8.89B 8.2B 7.6B 14.42B 964B 14.65B 98.27B 38.21B 476B 38.15B 37.32B 1,645B
Net income 2.69B 2.36B 2.17B 2.01B 3.82B 256B 3.89B 26.06B 10.13B 126B 10.12B 9.9B 436B 2.92B 2.56B 2.36B 2.19B 4.15B 278B 4.22B 28.28B 11B 137B 10.98B 10.74B 473B
Net Debt 6.73B 5.89B 5.42B 5.03B 9.54B 638B 9.7B 65.04B 25.29B 315B 25.25B 24.7B 1,089B 5.82B 5.1B 4.7B 4.35B 8.27B 553B 8.4B 56.33B 21.9B 273B 21.87B 21.39B 943B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-07-07 $76.29 +1.15% 4,683,665
26-07-06 $75.42 +0.83% 7,187,257
26-07-02 $74.80 +3.24% 4,361,046
26-07-01 $72.45 +0.82% 6,268,152
26-06-30 $71.86 -1.90% 8,322,247
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
76.29USD
Average target price
115.65USD
Spread / Average Target
+51.59%

Quarterly revenue - Rate of surprise